He received a bachelor degree in Mechanical Engineering from University of Gadjah Mada, Yogyakarta, Indonesia in 1995. Then, he joined Indonesian Aircraft Industries Ltd. (PT. IPTN/ Dirgantara Indonesia/ Indonesian-Aerospace Ltd), Bandung, Indonesia as a Fatigue and Fracture Mechanics engineer from 1995 to 1999. ALHAMDULILLAH, while working with PT. IPTN, he was given a sponsorship by the Ministry of National Education, Indonesia,for pursuing master degree in Mechanical Engineering at Institute of Technology Bandung (ITB), Indonesia (completed in 1998). In October 1999, he was awarded a prominent PhD studentship from the Queen Mary and Westfield Research Council, University of London, and ALHAMDULILLAH he successfully accomplished his PhD in Computational Mechanics in 2003.Prior to joining Universiti Tenaga Nasional, Malaysia, in July 2004, he was working as a visiting researcher at Inter University Center, Institute of Technology Bandung (ITB), Indonesia. In 2010, he joined University of Malaya, Malaysia, for the Department of Mechanical Engineering. Next, prior to joining University of Pertamina in 2019, he was working with Universiti Teknologi Brunei, Brunei Darussalam (in 2016). In 2025, ALHAMDULILLAH, he was very pleased to make a return to Universiti Malaya (Department of Mechanical Engineering), Malaysia.

Dr. Mohd Danish Ansari is an academician and researcher specializing in pharmaceutics, pharmaceutical nanotechnology, and advanced drug delivery systems. He currently serves as a lecturer at the Dept. of Pharmaceutical Technology, Faculty of Pharmacy, University of Malaya, Kuala Lumpur, Malaysia. His teaching portfolio spans pharmaceutical engineering, industrial pharmacy, novel drug delivery systems, pharmaceutical analysis, regulatory affairs, and dosage form design at both undergraduate and postgraduate levels. He also holds several academic leadership roles, including Course Coordinator (Quality Assurance), Head of the Certification Unit, member of the Universiti Malaya Research Ethics Committee (UMREC), Accreditation Task Force member, and Final Year Project (FYP) Coordinator. He actively contributes as a postgraduate thesis evaluator, PhD examiner, and academic administrator. Dr. Ansari earned his Ph.D. in Pharmaceutics from Jamia Hamdard, where his doctoral research focused on the development of novel vesicular spanlastic systems for enhancing the bioavailability of BCS Class II drugs via the transdermal route. He also completed his M.Pharm, B.Pharm, and D.Pharm from the same institution. His research interests include pharmaceutical nanotechnology, transdermal and targeted drug delivery, biomaterials, hydrogels, lipid and polymeric nanoparticles, nanomedicine, pharmacokinetics and pharmacodynamics, and regulatory sciences. In addition to academia, Dr. Ansari has professional experience as an associate scientific writer at leading life sciences consulting organizations, where he contributed to manuscript preparation, regulatory writing, medical information development, instructional design, data analytics, and scientific communications. Earlier in his career, he served as a lecturer in pharmaceutics and worked as a project assistant under a DST Nano Mission-funded project of the government of India, focusing on the formulation and in vivo evaluation of nanoemulsion-based drug delivery systems for osteoporosis management. Dr. Ansari is a GPAT-qualified professional and recipient of multiple Best Publication Awards for high-impact research contributions. His scholarly work reflects a strong commitment to innovation in nanomedicine and translational pharmaceutical research. Dr. Ansari has authored over 25 high-impact publications in Q1–Q3 journals, including pioneering work on nanospanlastics, lipid-polymer hybrid nanoparticles, SNEDDS, and nanoengineered delivery systems for neurological disorders, osteoporosis, and cancer. He has contributed book chapters on nanostructured drug carriers and fixed-dose combination techniques. His research has been recognized internationally, and he has presented at multiple conferences, receiving awards for oral presentations. His publications demonstrate a strong translational focus, bridging innovative nanotechnology with patient-centered therapeutic applications. Dr. Ansari serves as a peer reviewer for several national and international journals. His expertise in pharmaceutics, nanotechnology, and drug delivery enables him to critically evaluate manuscripts and contribute to maintaining high scientific standards in these publications.  

Dr. Julian Wong Joon Ip is a psychiatrist and medical lecturer with the Department of Psychological Medicine, Faculty of Medicine, Universiti Malaya. He graduated with Honours in Bachelor of Medicine and Bachelor of Surgery (MBBS) (Hons) from Monash University and later obtained his Master of Psychological Medicine (MPsy.Med.) from Universiti Malaya. Dr. Wong is actively engaged in undergraduate and postgraduate education, clinical practice, and academic research. He serves as a practicing psychiatrist at Universiti Malaya Medical Centre (UMMC), providing comprehensive inpatient and outpatient care. His clinical interests include psychiatric comorbidities, with a particular emphasis on consultation-liaison psychiatry, community-based mental health services, and psychotherapy. He is currently part of both the consultation-liaison psychiatry team and the Community Mental Health Services (CMHS) at UMMC. Dr. Wong is a certified Cognitive Behavioural Therapy for Insomnia (CBT-I) clinician, having completed a training program by Dr. Gregg Jacobs (University of Massachusetts Medical School). He has also completed Pre-Core Training in Intensive Short-Term Dynamic Psychotherapy (ISTDP) under Dr. Samuel Cheng at Changi General Hospital and is embarking on a 3-year Core Training program in ISTDP as a subspecialty focus from 2026 to 2028. He is also a certified TMS clinician, having completed the International Transcranial Magnetic Stimulation (TMS) Certification Course in London, organised by the Academy of Brain Stimulation. Dr. Wong actively promotes mental health literacy and wellness in the community. He frequently speaks at public forums, conferences, and symposia (locally, regionally, and internationally) to discuss latest evidence based clinical practices, promote mental wellness and improve mental health literacy in the community.